JA
Jagsonpal Pharmaceuticals Limited
JAGSNPHARM.BO · BSE
₹233.70 +0.45% (+₹1.05)
1M +2.91%
Market Cap ₹15.3B
P/E Ratio 33.73x
Div. Yield -
ROE 17.19%
Bulios Fair Price
₹159.49
31.8% downside
Trenutna cena
₹233.7
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica JAGSNPHARM.BO trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
16 /100
Expensive P/E 33.73x
EV/EBITDA 22.49x
P/S 5.22x
Growth
59 /100
Stable EPS growth 15.64%
Rev. growth 6.66%
FCF growth 0.24%
Profitability
77 /100
Strong Gross margin 55.42%
Net margin 15.48%
Op. margin 17.65%
Quality
80 /100
Excellent ROE 17.19%
ROIC N/A
ROA N/A
Debt
100 /100
Low Debt/Equity 0.00x
Int. coverage 57.52x
Net debt/EBITDA 0.00x
Stability
44 /100
Moderate Beta -0.28x
Rev. volatility 20.32%
EPS volatility 93.90%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o JAGSNPHARM.BO
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Manish Gupta
Employees
1,297
Headquarters
Gurugram